Skip to main content
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit

Updates regarding government operating status and resumption of normal operations can be found at

Kenneth Fischbeck, M.D.

Kenneth Fischbeck
NIH Distinguished Investigator
Neurogenetics Branch, NINDS

Adjunct Investigator, NHGRI
Division of Intramural Research

A.B. Harvard University, 1972
A.M. Harvard University, 1972
M.D. Johns Hopkins University, 1976

T: (301) 435-9318
F: (301) 480-3365
Building 35, Room 2A1000
BETHESDA, MD 20892-3705

Selected Publications

Dr. Fischbeck studies the mechanisms of hereditary neurological and neuromuscular disorders, with the goal of developing effective treatments for these conditions. His laboratory's areas of research include the polyglutamine expansion diseases (Huntington's disease, Kennedy's disease, and spinocerebellar ataxia), spinal muscular atrophy, Charcot-Marie-Tooth disease, muscular dystrophy, hereditary motor neuron disease, and Friedreich's ataxia. His laboratory studies the disease mechanisms of these conditions in cell culture and model systems. In addition, Dr. Fischbeck directs a genetic outreach program intended to identify and characterize patients and families with hereditary neurological diseases. His group has conducted a clinical trial of gentamicin treatment in patients with muscular dystrophy, and a trial of idebenone treatment for Friedreich's ataxia is ongoing. Efforts also are under way to develop new treatments for spinal muscular atrophy, muscular dystrophy, and the polyglutamine expansion diseases.

Top of page

Last Updated: July 17, 2012